Two Sigma Advisers’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Two Sigma Advisers’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-491,200	Closed	-$9.17M	–	2987
2022 Q1	$9.17M	Buy	491,200 +360,200	+275%	+$6.48M	0.02%	554
2021 Q4	$2.8M	Buy	+131,000	New	+$2.58M	0.01%	1023
2021 Q2	–	Sell	-37,400	Closed	-$722K	–	2786
2021 Q1	$722K	Buy	+37,400	New	+$659K	﹤0.01%	1833

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Two Sigma Advisers's OCDX Position: Q2 2022 in Review

Two Sigma Advisers sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 491,200 shares — an estimated $9.17M sold.

Two Sigma Advisers first reported a position in OCDX in Q1 2021 and held it in 3 quarters. The position peaked at $9.17M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Two Sigma Advisers reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Two Sigma Advisers sold 491,200 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $9.17M.
Two Sigma Advisers first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 3 quarters.
Two Sigma Advisers's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $9.17M in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.